MDP · Medexus Pharmaceuticals Inc. · Financials
Market Cap
160.90M CAD
Shares
31.43M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
$99.33M
-8.3%
FY2026
Net Income
-$2.39M
-206.5%
FY2026
Gross Margin
54.78%
+2.6pp
FY2026
Operating Margin
5.17%
-2.4pp
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 |
|---|---|---|
| $99.33M | $108.33M | |
| $54.41M | $56.58M | |
| 54.78% | 52.23% | |
| $5.14M | $8.22M | |
| 5.17% | 7.59% | |
| -$2.27M | $1.44M | |
| -$2.39M | $2.25M | |
| -2.41% | 2.07% |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.